Lysosomal Acid Lipase Deficiency (LAL-D) Treatment Market Growth and Forecast to 2032
Lysosomal Acid Lipase Deficiency (LAL-D) is a genetic disorder that results from mutations involving the LIPA gene, which codes for the LAL enzyme. The diagnosis is made using genetic tests, enzyme activity tests, and Imaging. LAL-D is a very rare autosomal recessive disease resulting from the deficiency of the LAL enzyme. LAL is essential for the breakdown of lipids that bring into the...
0 Comments 0 Shares 19 Views 0 Reviews